Publication details
DEVELOPMENT SAFETY UPDATE REPORT KDO_DC1311
| Authors | |
|---|---|
| Year of publication | 2023 |
| MU Faculty or unit | |
| Web | KDO_DC1311 |
| Description | The annual report gives the overview of the conduct of the clinical trial „Combined antitumor therapy with ex vivo manipulated dendritic cells producing interleukin-12 in children, adolescents and young adults with progressive, recurrent or primarily metastatic high-risk tumors“. The primary aim of the clinical trial is to study the safety of inovative medicinal product of somatic cell therapy. Masaryk University is the trial sponsor. |
| Related projects: |